Staff editor
Funds to be invested to further advance Clinical Microbiomics’ leading microbiome profiling and systems biology platform, and to expand into new offerings and markets
Marco Caspani, Chief Executive Officer at CSL Srl, discussed the challenges and the opportunity of producing anaerobic bacteria during the press conference on The Akkermansia Company.
Michael Oredsson, CEO at The Akkermansia Company, discussed with the new postbiotic supplement containing pastorised Akkermansia muciniphila.
Stijn Oste, Vice president Metagenics, head EMEA, presents the new supplement during the press conference held in Milan (Italy).
Denise Kelly (Investment Advisor at Seventure) discussed the next challenges and opportunities in the field of gut microbiome therapeutics.
Connect directly with the global microbiome partners.
Gallinée was founded in 2014 by Marie Drago, PharmD, a world recognized specialist in skin microbiome.
Even though probiotics market is expanding worldwide, EU consumers cannot be informed about the presence of probiotics in food and food supplements.
Sam Costello (The Queen Elizabeth Hospital in Adelaide) presented recent evidences about FMT and IBDs.
RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrence of C. difficile infection after antibiotic treatment
